Clinical Trials
5 trialsNCT01002924 2021-04-08
Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)
Endocyte
Phase 2 Completed
NCT01577654 2021-04-01
TARGET
Endocyte
Phase 2 Completed
NCT00511485 2015-02-27
Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)
Endocyte
Phase 2 Completed
NCT00507741 2015-01-07
Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)
Endocyte
Phase 2 Completed
NCT00722592 2015-01-07
PRECEDENT
Endocyte
Phase 2 Completed